ILF3-DT
gene geneOn this page
Summary
ILF3-DT (ILF3 divergent transcript, HGNC:27115) is a long non-coding RNA gene on chromosome 19p13.2.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27115 |
| Approved symbol | ILF3-DT |
| Name | ILF3 divergent transcript |
| Location | 19p13.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000267100 |
| Ensembl biotype | lncRNA |
| Entrez | 147727 |
| RNAcentral | URS000075B993 — lncRNA, 2032 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 lncRNA
ENST00000591501, ENST00000790961, ENST00000790962
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000591501 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004171711 | 10651859 | 10653879 |
Expression profiles
Bgee: expression breadth ubiquitous, 231 present calls, max score 90.26.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.2061 / max 111.6692, expressed in 1753 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179172 | 10.5559 | 1752 |
| 179170 | 0.5136 | 98 |
| 179171 | 0.1365 | 52 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adenohypophysis | UBERON:0002196 | 90.26 | gold quality |
| gastrocnemius | UBERON:0001388 | 90.22 | gold quality |
| muscle of leg | UBERON:0001383 | 89.74 | gold quality |
| pituitary gland | UBERON:0000007 | 89.48 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 89.23 | gold quality |
| left ovary | UBERON:0002119 | 89.21 | gold quality |
| nucleus accumbens | UBERON:0001882 | 88.96 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 88.93 | gold quality |
| right uterine tube | UBERON:0001302 | 88.76 | gold quality |
| thyroid gland | UBERON:0002046 | 88.67 | gold quality |
| body of uterus | UBERON:0009853 | 87.80 | gold quality |
| mucosa of stomach | UBERON:0001199 | 87.72 | gold quality |
| endocervix | UBERON:0000458 | 87.59 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 87.55 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 87.44 | gold quality |
| cerebellar cortex | UBERON:0002129 | 87.34 | gold quality |
| putamen | UBERON:0001874 | 87.30 | gold quality |
| apex of heart | UBERON:0002098 | 87.24 | gold quality |
| cerebellar vermis | UBERON:0004720 | 87.21 | gold quality |
| tibial nerve | UBERON:0001323 | 87.06 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 87.06 | gold quality |
| hypothalamus | UBERON:0001898 | 86.90 | gold quality |
| right ovary | UBERON:0002118 | 86.88 | gold quality |
| skin of leg | UBERON:0001511 | 86.76 | gold quality |
| ectocervix | UBERON:0012249 | 86.76 | gold quality |
| right lung | UBERON:0002167 | 86.66 | gold quality |
| cerebellum | UBERON:0002037 | 86.58 | gold quality |
| caudate nucleus | UBERON:0001873 | 86.47 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 86.47 | gold quality |
| lower esophagus | UBERON:0013473 | 86.41 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.37 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 6)
- Long noncoding RNA ILF3-AS1 promotes EZH2-mediated cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma. (PMID:28935763)
- The expression levels of lncRNA ILF3-AS1 was up-regulated in osteosarcoma tissues and cell lines, and was modulated by SP1. LncRNA ILF3-AS1 promoted osteosarcoma cells proliferation and metastasis via modulation of miR-212-SOX5 pathway. (PMID:30819403)
- LncRNA ILF3-AS1 mediated the occurrence of epilepsy through suppressing hippocampal miR-212 expression. (PMID:32404536)
- Up-regulated long non-coding RNA ILF3-AS1 indicates poor prognosis of nasopharyngeal carcinoma and promoted cell metastasis. (PMID:32962500)
- Mechanism underlying long noncoding RNA ILF3AS1mediated inhibition of cervical cancer cell proliferation, invasion and migration, and promotion of apoptosis. (PMID:34080029)
- LncRNA ILF3-AS1 mediates oxidative stress and inflammation through miR-504-3p/HMGB1 axis in a cellular model of temporal lobe epilepsy. (PMID:39135276)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.